VOOZH about

URL: https://www.hopkinspsychedelic.org/

⇱ Johns Hopkins Center for Psychedelic and Consciousness Resarch


Welcome to the world’s largest psychedelic science research center

Researchers at the Johns Hopkins School of Medicine are advancing the scientific understanding of psychedelics and their potential for treating mental health disorders, enhancing well-being, and expanding our understanding of consciousness.

Studies

Experiencing difficulties after using a psychedelic? 

The Johns Hopkins Integration Clinic offers specialized medical and psychotherapeutic support.

About

Our Vision

To advance the scientific understanding of psychedelics and their potential for treating mental health disorders, enhancing well-being, and expanding our understanding of consciousness.

Our Mission

To answer the most important questions in psychedelic research, therapy, and clinical education, and broaden the field of psychedelic science in collaboration with the best multi-disciplinary scientists in the world. We will conduct rigorous clinical trials that adhere to the highest ethical standards while elucidating underlying mechanisms driving psychedelic effects and therapeutic efficacy. We will provide evidence-based education to clinicians and the broader community to contribute to the development of innovative therapeutic approaches that benefit individuals and society. 

Our Leadership

We aim to be an example of conduct and thought in our research around all matters regarding psychedelics. To bring light to subjects that are understudied, to prepare the next generation of researchers, and to conduct clinical trials that are held to the highest standard.

The Johns Hopkins CPCR is a global leader in psychedelic research, with over 150 published studies covering a wide range of cutting-edge topics in the field.

Media

Browse featured articles and media to learn more about our findings.

Investigator Insights

The neuroscience of psychedelic drugs, music and nostalgia
Roland Griffiths & David Yaden || The Scientific Psychedelics Revolution and Embracing Mortality
Psychedelic-Assisted Therapy with Dr. Albert Garcia-Romeu | Being Well Podcast
Cultural Psychiatry and Psychedelics with Dr Sandeep Nayak

CPCR in the News

The State of Psychedelics

Oprah Daily describes the history of hallucinogenic medicines and personal accounts on existing research from universities and centers including the CPCR. Dr. Frederick Barrett discusses the “entropic effect” of psychedelics as well as the realistic risks and care that should be taken when handling the future of psychedelic research.

After FDA setback, psychedelic drugmakers distance themselves from a pioneer

Dr. David Yaden offers his perspective on the “real risks and benefits of psychedelics” after the FDA’s rejection of MDMA for the treatment of PTSD. He hopes that public sentiment will become more “balanced and nuanced” regarding the state of evidence on psychedelics as medicine.

Trouble for ecstasy? What MDMA’s FDA setback could mean for psychedelics

In early June, an advisory committee to the FDA voted against the effectiveness on MDMA as a treatment for post-traumatic stress disorder. Drs. Frederick Barrett and Alan Davis comment on the lessons that can be learned from the committee’s stance, viewing it as a learning experience for ongoing studies to follow “the most rigorous methods”.

Stay Connected

As Featured In:

Sign up for our newsletter

Interested in psychedelic research? Sign up for our email newsletter where we share the latest news and upcoming studies.

 FAQs

Contact Us

Center for Psychedelic and Consciousness Research
Joseph V. Brady Behavioral Biology Research Building
Johns Hopkins Bayview Medical Center
5510 Nathan Shock Drive
Baltimore, MD 21224

Phone: 410-550-2253
Directions & Campus Map